Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 24 04:00PM ET
323.77
Dollar change
+7.59
Percentage change
2.40
%
IndexS&P 500 P/E42.73 EPS (ttm)7.58 Insider Own0.57% Shs Outstand73.50M Perf Week-1.00%
Market Cap23.58B Forward P/E35.99 EPS next Y8.99 Insider Trans-25.46% Shs Float72.43M Perf Month-2.18%
Income568.70M PEG6.22 EPS next Q2.12 Inst Own96.61% Short Float1.71% Perf Quarter-17.02%
Sales2.93B P/S8.05 EPS this Y-4.11% Inst Trans-1.66% Short Ratio2.16 Perf Half Y-7.92%
Book/sh36.72 P/B8.82 EPS next Y16.09% ROA15.53% Short Interest1.24M Perf Year-13.90%
Cash/sh8.26 P/C39.19 EPS next 5Y6.87% ROE20.84% 52W Range310.00 - 415.73 Perf YTD-8.05%
Dividend Est.0.74 (0.23%) P/FCF61.08 EPS past 5Y23.49% ROI20.05% 52W High-22.12% Beta1.00
Dividend TTM0.79 (0.24%) Quick Ratio1.95 Sales past 5Y11.96% Gross Margin37.28% 52W Low4.44% ATR (14)9.57
Dividend Ex-DateJul 31, 2024 Current Ratio2.61 EPS Y/Y TTM3.48% Oper. Margin23.08% RSI (14)49.07 Volatility3.45% 2.80%
Employees10600 Debt/Eq0.11 Sales Y/Y TTM1.62% Profit Margin19.42% Recom1.92 Target Price398.77
Option/ShortYes / Yes LT Debt/Eq0.06 EPS Q/Q-16.09% Payout9.90% Rel Volume1.83 Prev Close316.18
Sales Surprise-3.74% EPS Surprise-12.70% Sales Q/Q-2.88% EarningsJul 25 BMO Avg Volume573.88K Price323.77
SMA200.28% SMA50-1.78% SMA200-9.01% Trades Volume1,040,210 Change2.40%
Date Action Analyst Rating Change Price Target Change
Feb-07-24Upgrade Jefferies Hold → Buy $323 → $536
Jun-16-23Upgrade BofA Securities Neutral → Buy $390 → $405
Apr-11-23Upgrade Stephens Equal-Weight → Overweight $330 → $400
Dec-14-22Initiated Deutsche Bank Hold $250
Nov-30-22Initiated UBS Neutral $250
Oct-28-22Downgrade BofA Securities Buy → Neutral $385 → $250
Nov-10-20Initiated KeyBanc Capital Markets Overweight $350
Oct-14-20Initiated Stephens Equal-Weight $300
Jul-21-20Upgrade BofA Securities Neutral → Buy $280
Apr-24-20Upgrade BofA/Merrill Underperform → Neutral $145 → $200
Today 07:10AM
06:10AM
06:00AM
Jul-22-24 09:51AM
Jul-17-24 04:01AM
06:00AM Loading…
Jul-11-24 06:00AM
Jun-21-24 01:37PM
Jun-13-24 07:02PM
Jun-06-24 02:31PM
02:25PM
May-29-24 06:00AM
May-28-24 06:00AM
May-24-24 04:57AM
May-09-24 03:43PM
Apr-30-24 09:19AM
06:00AM Loading…
06:00AM
Apr-29-24 07:40PM
Apr-27-24 01:07AM
Apr-26-24 11:34AM
11:07AM
10:56AM
03:12AM
Apr-25-24 10:31AM
09:12AM
08:34AM
07:10AM
07:02AM
06:43AM
06:08AM
06:00AM
12:10PM Loading…
Apr-24-24 12:10PM
Apr-22-24 09:44AM
Apr-18-24 10:01AM
Apr-17-24 07:44AM
Apr-11-24 06:00AM
Apr-01-24 07:36AM
Mar-14-24 04:46PM
12:07PM
Mar-13-24 07:27PM
06:57AM
Mar-12-24 03:00PM
Feb-29-24 11:31PM
Feb-28-24 04:30PM
Feb-27-24 01:01PM
Feb-23-24 12:03AM
Feb-20-24 06:00AM
Feb-19-24 09:51AM
Feb-18-24 01:26PM
Feb-16-24 10:21AM
08:38AM
Feb-15-24 11:56PM
07:41PM
01:34PM
10:08AM
09:30AM
08:18AM
07:10AM
07:08AM
06:18AM
06:00AM
Feb-13-24 08:57AM
Feb-12-24 09:16AM
Feb-07-24 07:33PM
08:00AM
Feb-01-24 06:00AM
Jan-22-24 10:33AM
06:51AM
Jan-04-24 06:41AM
Dec-06-23 06:00AM
Dec-05-23 11:59AM
Dec-04-23 03:00PM
Nov-29-23 06:03AM
Nov-19-23 08:15AM
Nov-14-23 11:23PM
Nov-13-23 07:00AM
Nov-08-23 11:58PM
Nov-03-23 11:52AM
Nov-01-23 06:00AM
Oct-30-23 12:24PM
06:26AM
06:11AM
Oct-27-23 12:22PM
11:35AM
11:16AM
08:03AM
Oct-26-23 04:39PM
10:06AM
09:30AM
09:28AM
07:15AM
06:33AM
06:08AM
06:00AM
Oct-25-23 10:21AM
Oct-23-23 06:00AM
Oct-20-23 07:39AM
Oct-19-23 10:01AM
Oct-16-23 06:00AM
Oct-12-23 04:59PM
06:00AM
West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Abraham SiljiSVP, Chief Technology OfficerJun 12 '24Sale330.781,800595,4042,860Jun 13 04:46 PM
Green Eric MarkPresident, CEO and Board ChairMay 07 '24Option Exercise58.8975,0004,416,500218,908May 09 03:38 PM
Green Eric MarkPresident, CEO and Board ChairMay 07 '24Sale366.6566,00024,199,050152,908May 09 03:38 PM
Winters ChadVP, Chief Accounting OfficerMar 11 '24Option Exercise173.22675116,9242,124Mar 12 11:46 AM
Winters ChadVP, Chief Accounting OfficerMar 11 '24Sale358.82815292,4361,309Mar 12 11:46 AM
Witherspoon CharlesVP & TreasurerFeb 28 '24Option Exercise102.512,019206,9683,998Mar 01 01:07 PM
Witherspoon CharlesVP & TreasurerFeb 28 '24Sale358.622,019724,0611,979Mar 01 01:07 PM
Green Eric MarkPresident, CEO and Board ChairFeb 27 '24Option Exercise57.3873,1324,196,314217,040Feb 29 04:35 PM
Green Eric MarkPresident, CEO and Board ChairFeb 27 '24Sale359.8564,13223,077,971152,908Feb 29 04:35 PM
Abraham SiljiSVP, Chief Technology OfficerFeb 23 '24Option Exercise173.227,0121,214,61911,672Feb 27 11:37 AM
Abraham SiljiSVP, Chief Technology OfficerFeb 23 '24Sale365.007,0122,559,3804,660Feb 27 11:37 AM
Winters ChadVP, Chief Accounting OfficerDec 01 '23Option Exercise156.18797124,4722,283Dec 05 07:33 PM
Winters ChadVP, Chief Accounting OfficerDec 01 '23Sale349.001,013353,5411,270Dec 05 07:33 PM
Witherspoon CharlesVP & TreasurerOct 31 '23Option Exercise223.841,190266,3703,025Nov 02 01:37 PM
Witherspoon CharlesVP & TreasurerOct 31 '23Sale322.371,190383,6231,835Nov 02 01:37 PM
Favorite Annette FSr. VP & Chief HR OfficerAug 30 '23Option Exercise83.472,000166,94016,877Sep 01 03:46 PM
Favorite Annette FSr. VP & Chief HR OfficerAug 30 '23Sale414.642,000829,27714,877Sep 01 03:46 PM
Reiss-Clark CindyChief Commercial OfficerAug 22 '23Option Exercise263.163,477915,0077,797Aug 24 07:24 PM
Reiss-Clark CindyChief Commercial OfficerAug 22 '23Sale393.343,4771,367,6434,320Aug 24 07:24 PM
Lai Quintin JVP Strat & Investor RelationsAug 11 '23Option Exercise125.4021,1012,646,11439,408Aug 15 02:50 PM
Lai Quintin JVP Strat & Investor RelationsAug 11 '23Sale395.1221,1018,337,48718,307Aug 15 02:50 PM
Witherspoon CharlesVP & TreasurerAug 09 '23Option Exercise137.871,680231,6133,509Aug 11 04:52 PM
Witherspoon CharlesVP & TreasurerAug 09 '23Sale396.541,680666,1871,829Aug 11 04:52 PM
Green Eric MarkPresident & CEOAug 08 '23Option Exercise57.3850,0002,869,000184,574Aug 10 02:50 PM
Abraham SiljiSVP, Chief Technology OfficerAug 08 '23Option Exercise102.518,160836,48212,369Aug 10 04:31 PM
Green Eric MarkPresident & CEOAug 08 '23Sale394.7744,00017,369,820140,574Aug 10 02:50 PM
Abraham SiljiSVP, Chief Technology OfficerAug 08 '23Sale397.188,1603,240,9724,209Aug 10 04:31 PM
Birkett BernardSr VP, Chief Fin & Ops OffAug 02 '23Option Exercise101.5222,3342,267,38326,700Aug 08 03:49 PM
Birkett BernardSr VP, Chief Fin & Ops OffAug 02 '23Sale370.3922,3348,272,2164,366Aug 08 03:49 PM